Journal of Molecular Endocrinology, 52 (1), R107-R123
This produces a shorter signal that more closely resembles a GHRH pulse
Clinical trials lasting 68 weeks showed that participants on semaglutide maintained significant weight loss throughout the treatment period, with continued improvements in metabolic markers including blood sugar, blood pressure, and cholesterol levels
In large-scale studies, semaglutide (the active ingredient in Ozempic and Wegovy) led to an average placebo-corrected weight loss of about 12.4% at the 2.4 mg dose
As a synthetic fragment of Thymosin Beta-4, it helps cells migrate to injured areas faster, increases blood flow through the formation of new blood vessels, and reduces systemic inflammation that slows the repair process down